What antibiotic covers bacterial sinusitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Antibiotic Treatment for Bacterial Sinusitis

Amoxicillin-clavulanate 875 mg/125 mg twice daily for 5-10 days is the preferred first-line antibiotic for acute bacterial sinusitis in adults, providing the best balance of efficacy against resistant pathogens and tolerability. 1

First-Line Treatment Algorithm

For Adults Without Recent Antibiotic Use (Past 4-6 Weeks)

Primary recommendation:

  • Amoxicillin-clavulanate 875 mg/125 mg twice daily achieves 90-91% clinical efficacy and 97-99% bacteriologic efficacy 2
  • Treatment duration: 5-10 days (shorter courses have comparable efficacy with fewer side effects) 1

Alternative options if amoxicillin-clavulanate unavailable:

  • Plain amoxicillin 500 mg twice daily (mild disease) or 875 mg twice daily (moderate disease) achieves 87-88% clinical efficacy 2
  • Cefpodoxime proxetil (87% efficacy), cefuroxime axetil (85% efficacy), or cefdinir (83% efficacy) 2

For Adults With Recent Antibiotic Use or Moderate Disease

Escalate to broader coverage:

  • Respiratory fluoroquinolones (levofloxacin 500-750 mg daily, moxifloxacin) achieve 92% clinical efficacy and 100% bacteriologic efficacy 2, 3
  • High-dose amoxicillin-clavulanate 4 g/250 mg daily (91% efficacy) 2
  • Ceftriaxone 1-2 g IV daily (91% efficacy) 2

For Penicillin-Allergic Patients

Non-Type I hypersensitivity (e.g., rash):

  • Second-generation cephalosporins: cefuroxime-axetil 2, 1
  • Third-generation cephalosporins: cefpodoxime-proxetil or cefdinir 2, 1
  • Risk of cross-reactivity with second/third-generation cephalosporins is negligible 1

True Type I hypersensitivity (anaphylaxis):

  • TMP/SMX (83% efficacy) or doxycycline (81% efficacy) 2
  • Avoid azithromycin and macrolides due to 20-25% resistance rates and only 77% efficacy 2, 1

Pediatric Dosing

Standard-dose for uncomplicated cases:

  • Amoxicillin 45 mg/kg/day divided twice daily for children without recent antibiotic use, not in daycare, and aged >2 years 1, 4, 5

High-dose for risk factors:

  • Amoxicillin-clavulanate 90 mg/kg/day (amoxicillin component) with 6.4 mg/kg/day clavulanate divided twice daily for children <2 years, daycare attendance, recent antibiotic use, or high local resistance 1, 4, 5
  • Treatment duration: 10-14 days 1, 4

Treatment Failure Protocol

Reassess at 72 hours (pediatrics) or 3-5 days (adults):

  • If no improvement or worsening, switch antibiotics considering limitations of initial agent 2, 1
  • For amoxicillin failure: switch to amoxicillin-clavulanate 2, 4
  • For amoxicillin-clavulanate failure: switch to respiratory fluoroquinolones (levofloxacin, moxifloxacin) 2, 1
  • For pediatric treatment failure at 72 hours: high-dose amoxicillin-clavulanate or ceftriaxone 50 mg/kg IM/IV 4

Anatomic Location Considerations

Maxillary sinusitis (most common):

  • Standard first-line antibiotics (amoxicillin-clavulanate) are appropriate 1

Frontal, ethmoidal, or sphenoidal sinusitis:

  • Reserve fluoroquinolones (levofloxacin, moxifloxacin) due to potential for serious complications 1

Adjunctive Therapies

  • Intranasal corticosteroids as adjunct to antibiotics in acute and chronic sinusitis 1
  • Short-term oral corticosteroids (e.g., dexamethasone 4 mg) for acute hyperalgic sinusitis (severe pain) or marked mucosal edema 1
  • Supportive measures: adequate hydration, analgesics, warm facial packs, sleeping with head elevated 1

Critical Pitfalls to Avoid

Resistance patterns:

  • 10-15% of S. pneumoniae are penicillin-resistant, 10-42% of H. influenzae produce β-lactamase, and nearly 100% of M. catarrhalis produce β-lactamase 5
  • High-dose amoxicillin (4 g/day) or amoxicillin-clavulanate (4 g/250 mg) needed for drug-resistant S. pneumoniae (DRSP) 2

Inappropriate antibiotic selection:

  • Never use azithromycin or macrolides as first-line therapy due to 20-25% resistance and inferior efficacy (77% vs 90-91% for amoxicillin-clavulanate) 2, 1
  • Reserve fluoroquinolones as second-line to prevent resistance development 1

Inadequate treatment duration:

  • Minimum 5 days, typically 7-10 days, or until symptom-free for 7 days 1, 5
  • Complete full course even after symptom improvement to prevent relapse 1

Watchful waiting option:

  • For uncomplicated acute bacterial sinusitis in adults with assured follow-up, watchful waiting without immediate antibiotics is appropriate, starting antibiotics if no improvement by 7 days or worsening at any time 1

References

Guideline

Treatment of Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Treatment for Acute Bacterial Sinusitis in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

First Line Antibiotic Treatment for Acute Bacterial Sinusitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.